|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
1.13/2.13
|
Enterprise Value
24.08B
|
Balance Sheet |
Book Value Per Share
23.86
|
Cash Flow |
Cash Flow Yield
0.17
|
Income Statement |
Total Revenue
10.58B
|
Operating Revenue Per Share
35.11
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2025/01/21 05:27 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
Fresenius Medical Care is the largest dialysis company in the world, treating over 300,000 patients from roughly 3,750 clinics across the globe as of mid-2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. |